August 26, 2025
Camelot study was one of the largest studies conducted on 287,789 patients and found that compare to traditional, cardiac monitoring methods, continuous and long-term cardiac monitoring was a associated with the highest diagnostic yield, and lowest likelihood of retesting and lead to lower, acute care healthcare resource utilization.
The Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events (CAMELOT) study is the first of and largest of its kind and found that Zio long-term continuous monitoring (LTCM) service was associated with the highest diagnostic yield and lowest likelihood of retesting.
Study design and methodology
The claims represent the coding that providers used to document the care they provided to their patients and the follow-up paths those same patients followed. The only claims included in the analysis were for patients who had not had previous cardiac monitoring, resulting in a balanced and comprehensive comparison of retest and healthcare resource utilization.
https://www.irhythmtech.com/us/en/healthcare-professionals/clinical-resource-center/camelot-study
